Beliefs, experience, and interest in pharmacotherapy among smokers with HIV

American Journal of Health Behavior

Volumn 38, Issue 2, 2014, Pages 284-296

  McQueen, Amy ^a   Shacham, Enbal ^b   Sumner, Walton ^a   Overton, E Turner ^c,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Division of Infectious Diseases   (United States)

Author keywords

Attitudes; HIV AIDS; Nicotine replacement therapy; Pharmacotherapy; Smoking cessation

Indexed keywords

NICOTINE GUM;

ADULT; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; CULTURAL ANTHROPOLOGY; ETHNOLOGY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MISSOURI; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SELF CONCEPT; SMOKING; SMOKING CESSATION; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER; UTILIZATION; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; CULTURE; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INSURANCE, HEALTH; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MISSOURI; PATIENT ACCEPTANCE OF HEALTH CARE; SELF EFFICACY; SMOKING; SMOKING CESSATION; SOCIAL CLASS; SURVEYS AND QUESTIONNAIRES; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84888862496     PISSN: 10873244     EISSN: 19457359     Source Type: Journal    
DOI: 10.5993/AJHB.38.2.14     Document Type: Article

References (79)

1. US Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Washington, DC: 2004.
2. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14(4): 824-835.
3. Lifson AR, Lando HA. Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep. 2012;9(3): 223-230.
4. Lipshultz SE, Mas CM, Henkel JM, et al. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults. Expert Rev Anti Infect Ther. 2012;10(6): 661-674.
5. Petoumenos K, Worm SW. HIV infection, aging and cardiovascular disease: epidemiology and prevention. Sex Health. 2011;8(4): 465-473.
6. Rahmanian S, Wewers ME, Koletar S, et al. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc. 2011;8(3): 313-319.
7. Vidrine DJ. Cigarette smoking and HIV/AIDS: Health implications, smoker characteristics and cessation strategies. AIDS Educ Prev. 2009;21(Suppl A): 3-13.
8. Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the Women's Interagency HIV Study. Am J Public Health. 2006;96(6): 1060-1065.
9. Grubb JR, Overton ET, Presti R, Onen NF. Reply to Ganesan et al. J Infect Dis. 2012;205(3): 518-519.
10. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. 2010;7(2): 69-76.
11. Onen NF, Overton ET. HIV and aging: two converging epidemics. Mo Med. 2009;106(4): 269-273.
12. Fiore MC, Jaen CR, Baker TB, et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2): 158-176.
13. Cromwell J, Bartosch WJ, Fiore MC. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA. 1997;278(21): 1759-1766.
14. Cokkinides V, Ward E, Jemal A, et al. Underuse of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1): 119-122.
15. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34(2): 102-111.
16. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002;16(1): 39-42.
17. Shuter J, Salmo LN, Shuter AD, et al. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey. AIDS Behav. 2011;16(2): 288-294.
18. Aveyard P, Begh R, Parsons A, West, R. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012;107(6): 1066-1073.
19. Chan SSC, Leung DYP, Abdullah ASM, et al. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction. 2011;106(6): 1155-1163.
20. Hughes JR, Rennard SI, Fingar JR, et al. Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Nicotine Tob Res. 2011;13(10): 955-964.
21. Moore D, Aveyard P, Connock M, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.
22. Cropsey KL, Hendricks PS, Jardin B, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38(10): 2541-2546.
23. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3): 545-554.
24. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009;104(11): 1891-1900.
25. Benard A, Bonnet F, Tessier JF, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitane Cohort. AIDS Patient Care STDS. 2007;21(7): 458-468.
26. Nahvi S, Cooperman NA. Review: the need for smoking cessation among HIV-positive smokers. AIDS Educ Prev. 2009;21(3 suppl): 14-27.
27. Phillips JC, Oliffe JL, Ensom MHH, et al. An overlooked majority: HIV-positive gay men who smoke. JMH. 2012;9(1): 17-24.
28. Grover KW, Gonzalez A, Zvolensky MJ. HIV symptom distress and smoking outcome expectancies among HIV+ smokers: a pilot test. AIDS Patient Care STDS. 2013;27(1): 17-21.
29. Burkhalter JE, Springer CM, Chhabra R, et al. Tobacco use and readiness to quit smoking in low-income HIVinfected persons. Nicotine Tob Res. 2005;7(4): 511-522.
30. Reynolds NR. Cigarette smoking and HIV: more evidence in action. AIDS Educ Prev. 2009;21(Suppl A): 106-121.
31. Chapman S, Wong WL, Smith W. Self-exempting beliefs about smoking and health: differences between smokers and ex-smokers. Am J Public Health. 1993;83(2): 215-219.
32. Oakes W, Chapman S, Borland R, et al. "Bulletproof skeptics in life's jungle": which self-exempting beliefs about smoking most predict lack of progression towards quitting? Prev Med. 2004;39(4): 776-782.
33. DeSantis AD. A couple of white guys sitting around talking: the collective rationalization of cigar smokers. J Contemp Ethnogr. 2003;32(4): 432-466.
34. Nicholas PK, Voss JG, Corless IB, et al. Unhealthy behaviours for self-management of HIV-related peripheral neuropathy. AIDS Care. 2007;19(10): 1266-1273.
35. Blumberg SJ. Guarding against threatening HIV prevention messages: an information-processing model. Health Educ Behav. 2000;27(6): 780-795.
36. Robinson W, Moody-Thomas S, Gruber D. Patient perspectives on tobacco cessation services for persons living with HIV/AIDS. AIDS Care. 2012;24(1): 71-76.
37. Gritz ER, Vidrine DJ, Lazev AB, et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1): 71-77.
38. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36(1): 75-85.
39. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30(5): 371-383.
40. Matthews AK, Conrad M, Kuhns L, et al. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013;27(1): 22-32.
41. Stanton CA, Lloyd-Richardson EE, Papandonatos GD, et al. Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. AIDS Educ Prev. 2009;21(3Suppl): 65-80.
42. Marteau TM, Aveyard P, Munafo MR, et al. Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomized controlled trial. PLoS ONE. 2012;7(4):e35249.
43. Mondy K, Overton ET, Tong S, et al. Metabolic syndrome in HIV within a representative U.S. patient population. Clin Infect Dis. 2007;44(5): 726-734.
44. Fishbein M. The role of theory in HIV prevention. AIDS Care. 2000;12(3): 273-278.
45. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2): 179-211.
46. Borland R, Yong H, Balmford J, et al. Do risk-minimizing beliefs about smoking inhibit quitting? Findings from the International Tobacco Control (ITC) four-country survey. Prev Med. 2009;49(2-3): 219-223.
47. National Cancer Institute. Dispelling myths about nicotine replacement therapy. Available at: http://cancercontrol. cancer.gov/tcrb/documents/ MythsaboutNRTFactSheet.pdf. Accessed May 22, 2008.
48. Christensen AJ, Moran PJ, Ehlers SL, et al. Smoking and drinking behavior in patients with head and neck cancer: effects of behavioral self-blame and perceived control. J Behav Med. 1999;22(5): 407-418.
49. Weinstein N, Marcus SE, Moser RP. Smokers' unrealistic optimism about their risk. Tob Control. 2005;14(1): 55-59.
50. Weinstein ND. Conceptualizing and measuring risk perception. Paper presented at the Conceptualizing and Measuring Risk Perceptions Workshop. Washington, DC; 2003. Available at: http://cancercontrol.cancer.gov/ brp/presentations/weinstein.pdf. Accessed August 13, 2013.
51. Smith SY, Curbow B, Stillman FA. Harm perception of nicotine products in college freshman. Nicotine Tob Res. 2007;9(9): 977-982.
52. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psyhcol Health. 1999;14(1): 1-24.
53. Gross B, Brose L, Schumann A, et al. Reasons for not using smoking cessation aids. BMC Public Health. 2008;8: 129-137.
54. Kleinjan M, van den Eijnden RJJM, Dijkstra A, et al. Excuses to continue smoking: the role of disengagement beliefs in smoking cessation. Addict Behav. 2006;31(12): 2223-2237.
55. Dijkstra A, De Vries H, Kok G, Roijackers J. Self-evaluation and motivation to change: social cognitive constructs in smoking cessation. Psyhcol Health. 1999;14(4): 747-759.
56. Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. Nicotine Tob Res. 2008;10(8): 1405-1413.
57. Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15(3): 271-283.
58. Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008;103(8): 1371-1378.
59. Barnes J, Dong CY, McRobbie H, et al. Hypnotherapy for smoking cessation. Cochrane Database of Systematic Reviews, Issue 10. Art. No.: CD001008. DOI: 10.1002/14651858.CD001008.pub2. 2010.
60. Thanavaro JL, Delicath TA. Auricular transcutaneous electrostimulation therapy and intensive counseling for the treatment of smoking cessation in a primary care practice. J Addict Nurs. 2010;21(4): 215-224.
61. White AR, Rampes H, Liu JP, et al. Acupuncture and related interventions for smoking cessation. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD000009. DOI: 10.1002/14651858.CD000009.pub3 2011.
62. Morojele NK, Stephenson GM, Rutter DR, Quine L. Addictive behaviours: predictors of abstinence intentions and expectations in the theory of planned behaviour. In Rutter DR, Quine L, (Eds). Social Psychology and Health: European Perspectives. Aldershot: Avebury; 1994: 47-88.
63. Beck L, Ajzen I. Predicting dishonest actions using the theory of planned behavior. J Res Pers. 1991;25(3): 285-301.
64. Gibbons FX, Gerrard M, Blanton H, Russell DW. Reasoned action and social relation: willingness and intention as independent predictors of health risk. J Pers Soc Psychol. 1998;74(5): 1164-1180.
65. DiClemente CC, Prochaska JO, Fairhurst SK, et al. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59(2): 259-304.
66. Fagerstrom KO, Kunze M, Schoberberger R, et al. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 1996;5(1): 52-56.
67. Toll BA, McKee SA, Martin DJ, et al. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine Tob Res. 2007;9(5): 597-605.
68. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction. 1993;88(6): 791-804.
69. National Institute on Alcohol Abuse and Alcoholism. Overview of alcohol consumption: moderate and binge drinking. Available at: http://www.niaaa.nih. gov/alcohol- health/overview-alcohol-consumption/moderatebinge- drinking. Accessed July 12, 2013.
70. Fu SS, Kodl MM, Joseph AM, et al. Racial/ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev. 2008;17(7): 1640-1647.
71. Bolt DM, Piper ME, Theobald WE, Baker TB. Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol. 2012;80(1): 54-65.
72. Loh WY, Piper ME, Schlam TR, et al. Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res. 2012;14(2): 131-141.
73. Shah SD, Wilken LA, Winkler SR, Lin SJ. Systematic review and meta-analysis of combination therapy for smoking cessation. J Am Pharm Assoc. 2003;48(5): 659-665.
74. Willems RA, Willemsen MC, Nagelhout GE, de Vries H. Understanding smokers' motivations to use evidencebased smoking cessation aids. Nicotine Tob Res. 2013; 15(1): 167-176.
75. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 update. Clinical Practice Guideline. Washington, DC: US Department of Health and Human Services, Public Health Service; 2008.
76. Zwiebel MA, Hughes V. Smoking cessation efforts in one New York city HIV clinic. J Assoc Nurses AIDS Care. 2010;21(1): 11-15.
77. Conner M, McEachan R, Jackson C, et al. Moderating effect of socioeconomic status on the relationship between health cognitions and behaviors. Ann Behav Med. 2013;46(1): 19-30.
78. Bansal MA, Cummings M, Hyland A, Giovino GA. Stopsmoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res. 2004;6(Suppl 3):S303-S310.
79. Cummings KM, Hyland A, Giovino GA, et al. Are smokers adequately informed about the health risks of smoking and medical nicotine? Nicotine Tob Res. 2004;6(Suppl 3):S333-S340.